id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1428-0020,FDA,FDA-2013-N-1428,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Publication,2017-05-25T04:00:00Z,2017,5,2017-05-25T04:00:00Z,,2017-05-25T15:14:06Z,2017-10711,0,0,09000064826103b1
FDA-2013-N-1428-0019,FDA,FDA-2013-N-1428,"Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry",Other,Guidance,2017-01-03T05:00:00Z,2017,1,2017-01-03T05:00:00Z,,2024-11-12T06:16:20Z,,1,0,0900006482446bec
FDA-2013-N-1428-0018,FDA,FDA-2013-N-1428,"Electronic Drug Product Reporting for Human Drug Compounding
Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and
Cosmetic Act; Guidance for Industry; Availability",Notice,Notice of Availability,2017-01-03T05:00:00Z,2017,1,2017-01-03T05:00:00Z,,2017-01-03T15:18:44Z,2016-31789,0,0,0900006482445e5f